RETINOIC ACID RECEPTOR AND SP-B GENE REGULATION

本工作的长期目标是研究视黄酸（RA）及其受体（RAR）通过控制呼吸上皮细胞中肺特异性基因表达来调节胎儿肺发育的功能作用，并将这些知识应用于临床治疗。表面活性剂蛋白B （SP-B）通过提高磷脂在空气-水界面的扩散速率来维持肺泡的稳定性，因此对氧化损伤后呼吸上皮的出生后呼吸适应和恢复至关重要。在这个应用中，我们建议确定RA和RAR在体外和体内刺激SP-B基因的分子机制。具体目的是：1)SP-B启动子上顺式维甲酸应答元件（RAREs）的鉴定。DNA足迹，凝胶电泳迁移转移试验和位点特异性诱变将被执行。研究将在呼吸道上皮细胞中进行，包括H441细胞系、ML3-15细胞系和肺泡II型上皮细胞的原代分离物；2) RAR与组织特异性转录因子TTF-1相互作用的表征。通过免疫共沉淀、Western blot和酵母双杂交系统鉴定RAR和TTF-1的精确相互作用域，以及它们在SP-B基因中结合和激活顺式作用元件中的作用；3)顺式RAR的表征，确定RA/RAR对SP-B基因在转基因小鼠体内时空表达的影响。野生型和RARE位点突变的hSP-B启动子将与CAT报告基因连接并引入小鼠。来自转基因肺组织切片的原位杂交和CAT检测将用于评估转基因肺组织切片的体内RARE杂交和CAT检测将用于评估体内RARE功能作用，确定SP-B启动子在细支气管和肺泡II型上皮细胞中的表达水平和特异性。

The long term goals of this work are to study functional roles of retinoic acids (RA) and their receptors (RAR) in regulating fetal lung development by controlling lung specific gene expression in respiratory epithelial cells, and to apply the knowledge to clinical treatment. Surfactant protein B (SP-B) maintains alveolar stability by enhancing the rate of spreading of phospholipid at the air-water interface, and therefore is critical to postnatal respiratory adaptation and recovery of respiratory epithelium following oxidant injury. In this application, we propose to determine molecular mechanisms by which RA and RAR stimulate the SP-B gene both in vitro and in vivo. The specific aims are: 1) Identification of cis-retinoic acid responsive elements (RAREs) on the SP-B promoter. DNA footprint, gel electrophoresis mobility shift assay and site-specific mutagenesis will be performed. The studies will be done in respiratory epithelial cells, including the H441 cell line, the ML3-15 cell line and primary isolates of alveolar Type II epithelial cells; 2) Characterization of the interaction between RAR and the tissue-specific transcription factor, TTF-1. Co-immunoprecipitation, Western blot and the yeast two-hybrid system will be performed to identify the precise interaction domains of both RAR and TTF-1, and their roles in binding and activating cis-acting elements in the SP-B gene; 3) Characterization of cis-RARE to determine the effects of RA/RAR on the temporal and spatial expression of the SP-B gene in transgenic mice. The wild type and RARE site-mutated hSP-B promoters will be linked to the CAT reporter gene and introduced into mice. In situ hybridization of tissue sections and CAT assay from transgenic lungs will be used to assess the in vivo RARE hybridization of tissue sections and CAT assay from transgenic lungs will be used to assess the in vivo RARE functional roles determining SP-B promoter expression levels and specificities in bronchiolar and alveolar Type II epithelial cells.